NOI.pdf

PRESOLICITATION NOTICE: INTENT TO AWARD A SOLE-SOURCE CONTRACT

INTENDED SOURCE: University of Georgia Research Foundation, Inc. – 310 East Campus Tucker Hall Room 406-Athens, GA 30602-1589

ANTICIPATED PERIOD of PERFORMANCE: 12 months from date of award

DESCRIPTION OF REQUIREMENT:

Pursuant to the authority of 41 USC 3304(a)(1), as implemented by Federal Acquisition Regulation (FAR) Subpart 6.302-1, the U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grant Services (OAGS) intends to award a sole source contract to University of Georgia Research Foundation, Inc. FDA has a need to gather data on L. monocytogenes in the tree-fruit production continuum, from orchards to post-harvest packing facilities in Georgia, as well as Salmonella in related watersheds in Georgia and Pennsylvania. Previous work in orchards within Pennsylvania shed light on L. monocytogenes movement within apple orchards and packing facilities. To build on this, examining stone fruit orchards in Georgia is needed.

Related to this, there is a need to survey Salmonella populations within Pennsylvania and Georgia watersheds. Since the total population present needs to be elucidated the use of CRISPR-SeroSeq is required to accomplish the exploration of total diversity within the examined watersheds.

The applicable North American Industry Classification System (NAICS) code for this acquisition is 111339 Other Noncitrus Fruit Framing.

The Government intends to solicit and negotiate directly with University of Georgia Research Foundation, Inc and no solicitation will be issued. This notice of intent is not a request for competitive proposals or quotations; however, if any interested party believes they can meet the above requirement, it may submit a statement of capabilities. The statement of capabilities must be submitted in writing and must contain material in sufficient detail to allow the government to determine if the party can perform the requirement. A determination by the Government not to compete this proposed requirement based on responses to this notice is solely within the discretion of the Government. All interested parties must express their interest and capabilities in writing via email to Telisha.Wilson@fda.hhs.gov within eleven (11) calendar days after the date of publication of this notice. No faxed documents will be accepted. If no responsive statements are received within eleven (11) calendar days, an award will subsequently be made to University of Georgia Research Foundation, Inc

This is a Federal contract opportunity; FDA-NOI-1255614 for services at Food and Drug Administration Office of Acquisitions and Grants Services - Rockville, MD.

Response Date: August 11, 2022 by 10:00AM Eastern Time. Please email responses to Telisha Wilson at Telisha.wilson@fda.hhs.gov.

No phone calls or faxes will be accepted.

mailto:Telisha.wilson@fda.hhs.gov